AGL 38.74 Increased By ▲ 0.18 (0.47%)
AIRLINK 214.95 Increased By ▲ 7.18 (3.46%)
BOP 10.05 Decreased By ▼ -0.01 (-0.1%)
CNERGY 6.68 Decreased By ▼ -0.40 (-5.65%)
DCL 9.70 Decreased By ▼ -0.29 (-2.9%)
DFML 40.25 Decreased By ▼ -0.89 (-2.16%)
DGKC 101.30 Decreased By ▼ -2.16 (-2.09%)
FCCL 35.81 Decreased By ▼ -0.54 (-1.49%)
FFBL 88.00 Decreased By ▼ -3.59 (-3.92%)
FFL 14.19 Decreased By ▼ -0.41 (-2.81%)
HUBC 137.10 Decreased By ▼ -2.33 (-1.67%)
HUMNL 14.00 Decreased By ▼ -0.10 (-0.71%)
KEL 5.78 Decreased By ▼ -0.19 (-3.18%)
KOSM 7.39 Decreased By ▼ -0.47 (-5.98%)
MLCF 46.60 Decreased By ▼ -0.68 (-1.44%)
NBP 66.38 Decreased By ▼ -7.38 (-10.01%)
OGDC 222.00 Decreased By ▼ -0.66 (-0.3%)
PAEL 38.80 Increased By ▲ 0.69 (1.81%)
PIBTL 9.00 Decreased By ▼ -0.27 (-2.91%)
PPL 200.50 Decreased By ▼ -5.35 (-2.6%)
PRL 39.79 Decreased By ▼ -0.06 (-0.15%)
PTC 26.21 Decreased By ▼ -0.41 (-1.54%)
SEARL 105.57 Decreased By ▼ -4.67 (-4.24%)
TELE 9.10 Decreased By ▼ -0.13 (-1.41%)
TOMCL 38.00 Decreased By ▼ -0.21 (-0.55%)
TPLP 13.90 Increased By ▲ 0.13 (0.94%)
TREET 25.90 Decreased By ▼ -0.55 (-2.08%)
TRG 59.23 Decreased By ▼ -1.31 (-2.16%)
UNITY 33.90 Decreased By ▼ -0.24 (-0.7%)
WTL 1.77 Decreased By ▼ -0.11 (-5.85%)
BR100 12,107 Decreased By -192.4 (-1.56%)
BR30 38,012 Decreased By -865.7 (-2.23%)
KSE100 112,989 Decreased By -1871.7 (-1.63%)
KSE30 35,554 Decreased By -641.8 (-1.77%)

GENEVA: The World Health Organization on Friday approved Johnson & Johnson's Covid-19 vaccine, after already authorising the jabs made by Pfizer-BioNTech and Oxford-AstraZeneca.

"Every new, safe and effective tool against Covid-19 is another step closer to controlling the pandemic," WHO chief Tedros Adhanom Ghebreyesus said in a statement.

The news comes after the single-dose jab won approval from the European Union on Thursday.

It has also received the green light from regulators in the United States, Canada and South Africa.

The World Health Organization said the J&J jab had been granted an "emergency use listing" which assesses the suitability of new health products during public health emergencies, and is quicker than the regular licensing system.

Comments

Comments are closed.